InMed Pharmaceuticals (INM) Total Liabilities (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Total Liabilities of $2.2 million for Q1 2026, down 0.72% year-over-year from $2.3 million in Q1 2025, and up 39.79% quarter-over-quarter from $1.6 million in Q4 2025.
InMed Pharmaceuticals (INM) Total Liabilities (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Total Liabilities history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 0.72% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 0.72% YoY), while the FY2025 annual figure was $2.1 million, down 18.0% from the prior year.
- Total Liabilities for Q1 2026 stood at $2.2 million, up from $1.6 million in the prior quarter.
- The five-year high for Total Liabilities was $4.6 million in Q1 2022, with the low at $1.3 million in Q3 2023.
- The 5-year median for Total Liabilities is $2.3 million (2025), against an average of $2.5 million.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities surged 138.23% in 2022, then plunged 62.55% in 2023.
- InMed Pharmaceuticals' Total Liabilities stood at $2.6 million in 2022, then slipped by 3.92% to $2.5 million in 2023, then slipped by 6.57% to $2.3 million in 2024, then tumbled by 30.88% to $1.6 million in 2025, then surged by 39.79% to $2.2 million in 2026.
- Business Quant data shows INM's Total Liabilities at $2.2 million in Q1 2026, $1.6 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | InMed Pharmaceuticals | 6.36 Mn | 1.11 Mn | - | 2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 2.15 Mn |
| Mar 31, 2025 | 2.26 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 2.62 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 2.58 Mn |
| Sep 30, 2022 | 3.58 Mn |
| Jun 30, 2022 | 3.71 Mn |
| Mar 31, 2022 | 4.60 Mn |
| Dec 31, 2021 | 5.22 Mn |
| Sep 30, 2021 | 2.11 Mn |
| Jun 30, 2021 | 2.40 Mn |